Western Alliance Bancorporation (WAL)
NYSEFinancialsBanks - RegionalSnapshot 2026-09-04
$80.95-0.06%
Close 2026-09-04 · 1-day change
NYSEFinancialsBanks - RegionalSnapshot 2026-09-04
QuarterlyIQ Insights · WAL
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $81 WAL trades at 1.1× p/b, below its 1.2× p/b peer median. Our $97 fair value sits above the price. It's a high-confidence read. Analysts target $36–$98. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $96.00 | — | — | Analyst | high |
| ddm gordon | 12M | $20.03 | — | — | TTM | high |
| graham number | 12M | $117.96 | — | — | TTM | high |
| Peer P/B | 12M | $93.43 | 1.2 | 75.33 | TTM | high |
| Peer P/E | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$36.00 – $98.00 (median $96.00) · 7 analysts · as of 2026-07-24
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $113.87 |
| 10.9 |
| 10.45 |
| ntm analyst |
| high |
| PEG | 12M | $233.56 | 28.4 | 8.21 | TTM | high |
| residual income | 12M | $75.91 | — | — | TTM | high |
| triangulated | 12M | $98.56 | 11.9 | 8.25 | Triangulated | high |
| Peer P/B | 3Y | $137.68 | 1.2 | 111.01 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $18.15 | 10.9 | 1.67 | Analyst | medium |
| PEG | 3Y | $355.22 | 28.4 | 12.49 | Analyst | medium |
| Peer P/B | 5Y | $178.29 | 1.2 | 143.75 | Hist. CAGR(prov.) | medium |
| PEG | 5Y | $469.78 | 28.4 | 16.51 | Analyst | medium |